Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hugh A. Sampson is active.

Publication


Featured researches published by Hugh A. Sampson.


Clinical & Experimental Allergy | 2017

Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts

Lucie Mondoulet; N. Kalach; Véronique Dhelft; Thibaut Larcher; C. Delayre-Orthez; Pierre-Henri Benhamou; Jonathan M. Spergel; Hugh A. Sampson; Christophe Dupont

Eosinophilic gastrointestinal disorders (EGIDs) are hypersensitivity disorders frequently triggered by food allergy and manifested by mucosal eosinophilic infiltration at any level of the gastrointestinal tract. This study established a model of gastric eosinophilia in peanut‐sensitized piglets to evaluate the efficacy of epicutaneous immunotherapy (EPIT) for its treatment.


Frontiers in Immunology | 2018

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice

Vincent Dioszeghy; Lucie Mondoulet; Leo Laoubi; Véronique Dhelft; Camille Plaquet; Adeline Bouzereau; C. Dupont; Hugh A. Sampson

The skin is a major immunologic organ that may induce protection, sensitization or tolerance. Epicutaneous immunotherapy (EPIT) has been proposed as an attractive strategy to actively treat food allergy and has been shown to induce tolerance in sensitized mice through the induction of Foxp3+ regulatory T cells (Tregs), especially CD62L+ Tregs. Among immune cells in the skin, dendritic cells are key players in antigen-specific immune activation or regulation. The role of different populations of skin DCs in tolerance induction remains to be elucidated. Using OVA-sensitized BALB/c mice, we demonstrated that the application of a patch containing OVA-A647 to the skin resulted in allergen uptake by Langerhans cells (LCs) and CD11b+ dermal cDC2 and subsequent migration into skin draining lymph nodes. These 2 populations induced Foxp3 expression in CD4+ cells in vitro. Only LCs induced LAP+ cells and CD62L+ Tregs. Using Langerin-eGFP-DTR mice, we analyzed the role of LCs in the mechanisms of tolerance induction by EPIT in vivo. Following complete depletion of LCs, a dramatic decrease in the number of OVA+ DCs and OVA+ CD11b+ dermal cDC2 was observed in skin draining lymph nodes 48 h after epicutaneous application. Likewise, 2 weeks of EPIT in non-depleted mice induced Foxp3+ Tregs, especially CD62L+, and LAP+ Tregs in skin draining lymph nodes and spleen, whereas no induction of Tregs was observed in LC-depleted mice. Following 8 weeks of treatment, EPIT-treated mice showed significant protection against anaphylaxis accompanied by a significant increase of Foxp3+ Tregs, especially CD62L+ Tregs, which was not seen in the absence of LCs. In summary, although both LCs and CD11b+ dermal cDC2s could induce regulatory T cells, the absence of LCs during EPIT impaired treatment efficacy, indicating their crucial role in skin-induced tolerance.


The Journal of Allergy and Clinical Immunology | 2017

Treatment of eosinophilic gastritis by epicutaneous immunotherapy (EPIT) in peanut allergic piglets

Lucie Mondoulet; Nicolas Kalach; Véronique Dhelft; Thibaut Larcher; Carine Delayre-Orthez; Hugh A. Sampson; Pierre-Henri Benhamou; Christophe Dupont


The Journal of Allergy and Clinical Immunology | 2017

Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch

Sophie Wavrin; Lucie Mondoulet; Vincent Dioszeghy; Emilie Puteaux; Véronique Dhelft; Camille Plaquet; C. Dupont; Pierre-Henri Benhamou; Hugh A. Sampson


The Journal of Allergy and Clinical Immunology | 2018

Phenotypic changes and IDO over-expression in splenic dendritic cells after epicutaneous immunotherapy

Benjamin Pelletier; Lucie Mondoulet; Emilie Puteaux; Sylvain Tilleul; Fabien Delisle; Christophe Dupont; Hugh A. Sampson


The Journal of Allergy and Clinical Immunology | 2018

Unique epigenetic signature in T cell compartment after epicutaneous immunotherapy in peanut sensitized mice

Lucie Mondoulet; Vincent Dioszeghy; Camille Plaquet; Elodie Roche; Véronique Dhelft; Florence Busato; Christophe Dupont; Hugh A. Sampson; Jörg Tost


The Journal of Allergy and Clinical Immunology | 2018

Epicutaneous immunotherapy with peanut directly targets Langerhans cells in human skin

Vincent Dioszeghy; Emeline Pages; Christophe Dupont; Hugh A. Sampson; Pascal Descargues; Lucie Mondoulet


Journal of Investigative Dermatology | 2018

091 NativeSkin ® , an immunocompetent human skin model to study antigen uptake and processing by Langerhans cells

E. Pagès; Lucie Mondoulet; E. Bonnefont; E. Braun; V. Dhelft; Christophe Dupont; Hugh A. Sampson; P. Descargues


The Journal of Allergy and Clinical Immunology | 2017

Foxp3+ CD62L+ Tregs induced by EPIT have the potency to suppress effector T cells proliferation in specific and bystander conditions

Benjamin Pelletier; Lucie Mondoulet; Véronique Dhelft; Camille Plaquet; C. Dupont; Pierre-Henri Benhamou; Hugh A. Sampson


The Journal of Allergy and Clinical Immunology | 2017

EPIT decreases T1D incidence in sensitized non obese diabetic mice: a likely bystander effect of EPIT-induced Tregs

C. Dupont; Benjamin Pelletier; Véronique Dhelft; Hugh A. Sampson; Pierre-Henri Benhamou; Lucie Mondoulet

Collaboration


Dive into the Hugh A. Sampson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christophe Dupont

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Dupont

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge